Overview

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This study is a Phase 2 trial to test the efficacy of LY686017 in the treatment of Social Anxiety Disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Paroxetine